Navigation Links
Bend Research Announces Schedule of Events at 2011 AAPS Annual Meeting and Exposition
Date:10/18/2011

BEND, Ore., Oct. 18, 2011 /PRNewswire/ -- Bend Research Inc. (www.bendresearch.com), a leading independent drug-formulation development and manufacturing company, has announced a full schedule of events at the 2011 annual meeting and exposition of the American Association of Pharmaceutical Scientists (AAPS) in Washington, D.C.

"Bend Research's business model has changed significantly over the last few years and we are now working with more than 70 clients," said Jim Nightingale, President of Bend Research. "Many people are interested in that evolution and we're eager to talk with them about what it means in terms of partnership opportunities. But we also want to emphasize the things that haven't changed: our focus is still on offering the scientific and engineering excellence that has made us a leader in developing drug-delivery technologies. Examples of that work are what we are sharing at AAPS this year."

The company will host two colloquiums, both at the Walter E. Washington Convention Center. The first, titled "Development and Robust Manufacturing of a Dry Powder Intranasal Vaccine against Norovirus," will be at 1:00 p.m. Oct. 24 in Room 158. It will feature guests from Bend Research, LigoCyte Pharmaceuticals and Lovelace Respiratory Research Institute.

"We are excited to present these novel results, which highlight a great collaboration," said Nightingale.

The second colloquium, titled "Amorphous Spray-Dried Dispersion Process Scale-Up and Quality by Design," will be at 2:00 p.m. Oct. 25 in Room 156. It will feature speakers from Bend Research, Vertex Pharmaceuticals, Bristol-Myers Squibb, and Hovione.

Space in each colloquium is limited to 60 people and guests are requested to register in advance at bendresearch.com/content/2011-aaps-annual-meeting-exposition.

In addition, Bend Research will be presenting the following eight posters at the annual meeting.

Bend Research Announces 2011 AAPS Schedule

  • "An Automated, Aseptic Sampling System for Improved Bioreactor Process Control," by Adam Carroll and David Newbold from 8 a.m. to noon Oct. 26 (Poster W4386)

  • "An Inhalable Formulation of Nanocrystalline Camptothecin for the Treatment of Lung Cancer," by Jeff Breit and David Vodak from 8 a.m. to noon Oct. 27 (Poster R6075)

  • "Amorphous Spray-Dried Dispersion (SDD) Formulation Screening," by Rod Ketner and Doug Lorenz from 1 to 5 p.m. Oct. 26 (Poster W5239)

  • "Surface Characterization of Compound X and HPMCAS Spray-Dried Dispersion Particles," by David Vodak, David Lyon, and Dwayne Friesen from 1 to 5 p.m. Oct. 26 (Poster W5265)

  • "In Vitro Performance of Spray-Dried Dispersions of Low-Solubility Drugs Using Several Dispersion Polymers," by Mike Morgen, Brice Murri, Rory Morgan, and Travis Ringo from 1 to 5 p.m. Oct. 26 (Poster W5251)

  • "Nanoparticles for Improved Local Retention After Intraarticular Injection into the Knee," by Mike Morgen and Warren Miller from 8 a.m. to noon Oct. 26 (Poster W4155)

  • "Spray-Dried Dispersion Formulation for Oral Solubilization of a Low-Solubility Histone Deacetylase Inhibitor," by Corey Bloom, Tom Whitehead, Fred Jordan, and Steve Shuttleworth from 1 to 5 p.m. Oct. 26 (Poster W5221)

  • "Development and Validation of a Wet Particle Size Method for a Water-Soluble Jet-Milled Active Pharmaceutical Ingredient," by Judson King (developed with Transcept) from 1 to 5 p.m. Oct. 26 (Poster W5340)

Bend Research will be at Booth 1813 in the convention center exhibit hall, where it will host its traditional "Booth Bar" happy hours from 3:00 to 5:30 p.m. Oct. 24 and from 4 to 6:30 p.m. Oct. 25.

"I'm very proud of what we are sharing at AAPS," said Nightingale. "It shows the high-caliber work that any client can expect from Bend Research."

About Bend Research Inc.

For more than 35 years, Bend Research has worked with clients to create value to solve their most difficult scientific and technical problems and advance new medicines that improve human health. This success is based on the company's ability to develop, advance, and commercialize pharmaceutical technologies, grown from a solid base of scientific and engineering fundamental understanding.

Bend Research advances promising drug candidates from conception through commercialization by providing formulation and dosage-form support, assisting in process development and optimization, and manufacturing clinical-trial quantities of drug candidates in its cGMP facilities. Bend Research is a leader in novel formulations, including solubilization technologies such as spray-dried dispersions and hot-melt extrusion formulations, as well as controlled-release, inhalation, and biotherapeutics technologies.

The company has more than 240 employees based in four state-of-the-art facilities in Bend, Oregon, USA.


'/>"/>
SOURCE Bend Research Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. VisionSpring Research Finds Seeing to be the Most Important of Five Senses
2. Techstreet and the ISPE Extend Partnership to Expedite Drug Research with Subscription Offering for Life Science Engineers
3. Elsevier Offers 950 New Health Titles to Research4Life
4. PAREXEL and National University of Singapore Establish Program in Singapore to Meet Increasing Demand in Asia for Clinical Research Talent
5. New Research Shows Chronic Pain is not Being Adequately Measured[1]
6. New Research Shows PET Imaging Effective in Predicting Lung Cancer Outcomes
7. Inovio Pharmaceuticals Synthetic Vaccine for Cancer Recognized as Most Promising Research at Global Vaccine Congress
8. Research Presented at The Obesity Society Meeting Shows Link Between BMI and Sleep Patterns
9. OncoMed Pharmaceuticals Names Dr. Jakob Dupont VP Clinical Research
10. Adeonas Planned Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrigs Disease is Hot Topic at 2011 California ALS Research Summit
11. St. Jude Childrens Research Hospital Discovery Aided Quest for Adult Cancer Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... TREE, Colo. , March 29, 2017  Zynex (OTCQB: ... manufacture and sale of non-invasive medical devices for pain ... today that it will host the Company,s 2016 full-year ... a.m. Eastern Time.) The Company expects to ... 31, 2017. ...
(Date:3/29/2017)... , March 29, 2017 According to a new ... Type (Gas-Filled Detectors, Geiger Muller, Survey Meter, Solid-State), Products (Personal Dosimeters, OSL, ... 2021" published by MarketsandMarkets, the market is expected to reach USD 1,215.4 ... of 6.5% from 2016 to 2021. Continue ... ...
(Date:3/29/2017)... , March 29, 2017  The Pharmaceutical Care ... a new PhRMA report on patient out-of-pocket spending: ... Medicare and Medicaid Services (CMS), the average amount spent ... 13% of drug spending in 2016, down from 23% ... a pricing problem, not a coverage problem. Health plans ...
Breaking Medicine Technology:
(Date:3/30/2017)... NC (PRWEB) , ... March 30, 2017 , ... ... will host the live audio conference “ Preventing Hospital Readmissions Through Discharge Planning ... 12, 2017 at 1:00 pm ET. This conference discusses strategies to prevent readmissions ...
(Date:3/29/2017)... ... 2017 , ... In the United States alone, up to 36% of primary ... of metastatic brain tumors(3). Though most meningiomas are benign, metastatic brain tumors are known ... effective treatment options, the San Diego Gamma Knife Center offers a precision-medicine ...
(Date:3/29/2017)... ... March 30, 2017 , ... CHARM CITY RUN WELCOMES MERCY MEDICAL CENTER ... Mercy Medical Center will serve as the official title sponsor of the Baltimore Women’s ... 25, 2017, thousands of women will walk or run the course around the Baltimore ...
(Date:3/29/2017)... ... March 29, 2017 , ... Wells Pharmacy Network, a ... at the upcoming World Congress, in Hollywood Florida April 6-8, 2017. , Ben ... the visionary leader in the training of physicians, scientists, and members of the ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... FASTBRACES® in Carnegie, OK, from Dr. Jamie Cameron, with or without a ... compared to traditional orthodontic treatment. Depending on each patient’s case, treatment with the ...
Breaking Medicine News(10 mins):